Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
With a market cap of 54.75B, Natera(NTRA) trades at $320.90. The stock has a price-to-earnings ratio of -235.35.
On 2026-08-10, Natera(NTRA) stock moved within a range of $310.95 to $326.03. With shares now at $320.90, the stock is trading +3.2% above its intraday low and -1.6% below the session's peak.
Trading activity shows a volume of 1.57M, compared to an average daily volume of 1.46M.
Over the past 52 weeks, Natera(NTRA) stock has traded between a high of $326.03 and a low of $149.38.
Over the past 52 weeks, Natera(NTRA) stock has traded between a high of $326.03 and a low of $149.38.
NTRA News
Morgan Stanley raised the firm’s price target on Natera (NTRA) to $355 from $310 and keeps an Overweight rating on the shares. Unlock powerful investing tools...
In recent trading, shares of Natera Inc (Symbol: NTRA) have crossed above the average analyst 12-month target price of $100.75, changing hands for $105.29/share...
In early August 2026, Natera reported second-quarter revenue of US$752.75 million with higher testing volumes and narrower losses, raised full-year 2026 revenue...
Analyst ratings
88%
of 24 ratingsMore NTRA News
Key Points Billionaire investor Stanley Druckenmiller has a long track record of success. His Duquesne Family office only holds one "Magnificent Seven" stock,...
Natera (NTRA) is back in focus after reporting Q2 2026 earnings on August 6, with revenue of US$752.75 million and a narrower net loss, alongside fresh regulato...
(RTTNews) - Natera Inc. (NTRA) on Thursday reported a narrower second-quarter loss as revenue surged 38% on higher testing volumes and pricing improvements. The...
Natera Inc. (NTRA) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident i...
(RTTNews) - Natera, Inc. (NTRA), a genetic testing company said on Wednesday that it has filed for approval in Japan to use its Signatera test as a companion di...
It can pay to track what the big investors on Wall Street are trading in quarterly 13-F filings. This quarter, legendary hedge fund manager Stanley Druckenmille...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.